Chapter 86 : Introduction

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in

Introduction, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818722/9781555818715_CH86-1.gif /docserver/preview/fulltext/10.1128/9781555818722/9781555818715_CH86-2.gif


Systemic autoimmune diseases are often associated with the production of autoantibodies that recognize a diverse array of cytoplasmic and nuclear antigens. These autoantibodies are used as adjuncts in the diagnosis of autoimmune disease, for monitoring disease activity and severity, and for predicting the outcome of autoimmune disease. As the diagnosis of systemic autoimmune disease is not always straightforward, autoantibody testing has the potential to improve our ability to diagnose complex autoimmune disorders. However, autoantibody test results, particularly those based on enzyme-linked immunosorbent assays (ELISAs) and other solid-phase assays, must be interpreted with caution due to their high sensitivity and the possibility of false-positive results. It is important to interpret the results of autoantibody tests in light of both the clinical context and the methodology employed. In some cases, confirmatory testing, analogous to the use of Western blotting to verify positive ELISA test results for HIV infection, is warranted.

Citation: Reeves W. 2016. Introduction, p 839-842. In Detrick B, Schmitz J, Hamilton R (ed), Manual of Molecular and Clinical Laboratory Immunology, Eighth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555818722.ch86
Highlighted Text: Show | Hide
Loading full text...

Full text loading...



This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error